Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Gini G, Tani M, Tucci A, Marcheselli L, Cesaretti M, Bellei M, Pascarella A, Ballerini F, Petrini M, Merli F, Olivieri A, Lanza F, Annibali O, Zilioli VR, Liberati AM, Tisi MC, Arcari A, Marino D, Musuraca G, Pavone V, Fabbri A, Pozzi S, Mannina D, Plenteda C, Celli M, Luminari S.
Gini G, et al. Among authors: pozzi s.
Blood. 2023 Oct 26;142(17):1438-1447. doi: 10.1182/blood.2022019173.
Blood. 2023.
PMID: 37418685
Free article.
Clinical Trial.